1998
DOI: 10.1016/s0264-410x(97)00188-6
|View full text |Cite
|
Sign up to set email alerts
|

Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
18
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(19 citation statements)
references
References 39 publications
1
18
0
Order By: Relevance
“…They revealed that MDP and other muramylpeptides of an appropriate size and structure provoked the necrotic reaction, while PGM and other bacterial immunomodulators, which shared many bioactivities with muramypeptides, did not [44]. Numerous MDP variants have been developed to overcome limitations of toxicity, but retaining adjuvant effects [5][6][7][8][9][10][11][12]. Reports mostly agree that all synthesized derivates of MDP could be useful immunoadjuvants.…”
Section: Experimental Groupsmentioning
confidence: 99%
See 1 more Smart Citation
“…They revealed that MDP and other muramylpeptides of an appropriate size and structure provoked the necrotic reaction, while PGM and other bacterial immunomodulators, which shared many bioactivities with muramypeptides, did not [44]. Numerous MDP variants have been developed to overcome limitations of toxicity, but retaining adjuvant effects [5][6][7][8][9][10][11][12]. Reports mostly agree that all synthesized derivates of MDP could be useful immunoadjuvants.…”
Section: Experimental Groupsmentioning
confidence: 99%
“…A variety of MDP analogs and derivatives have also been synthesized and their adjuvant activities have been examined [5][6][7][8][9][10][11][12]. MDP and its derivates are now known to be PAMPs [13].…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Smaller size peptidoglycans as well as some peptidoglycan fragments of well defined structures, the best known of which are muramyl peptides, had been extensively studied as possible adjuvants for human and animal vaccines. 3,4,5 Muramyl peptides are considered to be structural fragments of the monomeric peptidoglycans (e.g. PGM, 1, GlcNAc-MurNac-L-Ala-D-isoGln-mesoDAP(εNH 2 )-DAla-D-Ala, Figure 1) of bacterial cell walls, and MDP (muramyl dipeptide; N-acetyl-muramyl-L-alanyl-Disoglutamine) is known as the smallest synthetic adjuvant molecule capable of replacing whole Mycobacteria in Freund's adjuvant.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Immunostimulating activity of a smaller size peptidoglycans with well defined structures, that are not immunogenic and are devoid of pyrogenicity and toxicity, has been studied extensively, since such compounds could be considered for the use as adjuvants for human and animal vaccines. 3,4 Peptidoglycan monomer (PGM) studied in this work is a disaccharide pentapeptide b-D-GlcNAc-(1?4)-D-MurNAc-L-Ala-D-isoGlnmesoDAP(eNH 2 )-D-Ala-D-Ala ( Fig. 1) originating from Brevibacterium divaricatum.…”
Section: Introductionmentioning
confidence: 99%